The Increased Importance of Exercise with Weight Loss Medication

For decades, traditional wisdom has believed that in order to lose weight, you have to eat less and move more. Of course, that’s easier said than done. That’s why drugs like Wegovy are so innovative. By suppressing appetite, they help to tackle the first part of the equation, which usually leads to dramatic weight loss. But what about the second one? If weight loss pills are reducing the number of scales, should we still head to the gym? And how do these drugs affect our athletic ability?

What has become clear is that it may be even more important for those taking these medications than those who don’t. The ability of semaglutide to induce rapid weight loss (see “How do they work?” below) also leads to a significant decrease in muscle mass. For example, a 2021 study of 95 people who were overweight or obese taking semaglutide found that their lean body mass was reduced by almost 10% on average, 68 weeks later.

This article is part of a special series investigating the GLP-1 agonist boom. Click here for details.

Lean body weight covers body tissues such as muscles and bones. Therefore, these results suggest that both are affected when taking weight loss medications, Signee Sørensen Torekov at the University of Copenhagen explains. These drugs guide people to burn fewer calories, so the body needs to break down fat, muscle, and even bones for nutrients.

“Our understanding is that up to about 40% of the overall weight loss seen in semaglutide is thought to be due to the loss of muscle mass,” he said.

Source: www.newscientist.com

Potential long-term consequences of measles: immune system memory loss and encephalitis

Measles is not just a rash and fever.

The outbreak of the disease in West Texas has sent 29 people, most of them, to hospitals, as they continue to grow. Two people have died, including a six-year-old child.

It remains to be seen how many people have become ill in the outbreak. There have been at least 223 confirmed cases, but experts believe hundreds more people may have been infected since late January. As public health officials try to slow the spread of the highly contagious virus, some experts are worried about long-term complications.

Measles is different from other childhood viruses that come and go. In severe cases, it can cause pneumonia. According to the Centers for Disease Control and Prevention, approximately one in 1,000 patients develop encephalitis or encephalitis or encephalitis, with one or two deaths in 1,000 people.

This virus can wipe out the immune system, a complication known as “immune amnesia.”

When you get sick with a virus or bacteria, the immune system has the ability to form memories that can quickly recognize and respond to pathogens if they are encountered again.

Measles targets cells in the body, such as plasma cells and memory cells, and contains their immunological memory, and destroys some of them in the process.

“No one can escape this,” said Dr. Michael Mina, a vaccine expert and a former professor of epidemiology at the Harvard Chan School of Public Health.

In a 2019 survey, Mina and his team discovered that measles infections can be wrecked from anywhere 11% to 73% of human antibody stockpiledepends on how serious the infection is. This means that if people had 100 antibodies to Chicken Pox before they developed measles, they would be left at just 50 after measles infection, potentially catching them and getting sick.

Iwasakimon, professor of immunology at Yale University School of Medicine, said: You forget who the enemy is. ”

Virtually everyone who contracts measles weakens the immune system, but some are hit harder than others.

“There's no world where you get measles and it won't destroy some [immunity]He said. “The problem is that it will destroy enough to have clinical impact.”

In a previous study in 2015, Mina presumed that the virus was a virus before vaccination, when measles was common It may be related to half of childhood deaths due to infectionmainly from other diseases such as pneumonia, sepsis, diarrheal diseases, meningitis.

Researchers found that after measles infection, the immune system was suppressed almost immediately and remained intact for two to three years.

“Immune amnesia begins as soon as the virus replicates in them [memory] Cells,” Mina said.

The best protection against serious complications is the measles vaccine. Two doses of the vaccine are 97% effective in preventing infection.

What is “immune amnesia”?

Our bodies are constantly exposed to a variety of bacteria and viruses in our environment. Over time, our immune system learns to remember a particular intruder and can take action immediately if we find something that doesn't belong to our body.

“Children are in contact with all sorts of microorganisms, and most of those encounters have not led to illness,” said Dr. Adam Ratner, pediatrician and director of the Department of Pediatric Infectious Diseases at NYU Langone Health. “Children often recover and have memories, so if they see the same strain of the virus that causes diarrhea, they will be the second disease they are exposed to.”

With immune amnesia, he said that if people are exposed to strains of the same virus again, their bodies will act as if it was the first time they had it and they don&#39t have that robust protection.

This means that the measles virus can destroy the immunity that people have accumulated over time, such as pneumonia, colds, flu, bacteria, and more that can cause other pathogens.

Mina elicited a comparison with HIV, saying that the level of immunosuppression in severe measles infection can be compared to HIV that has not been treated for years. However, he warned that HIV affects various parts of the immune system, and that people&#39s immune systems can ultimately recover from measles.

How does measles destroy the immune system?

Highly contagious viruses can destroy long-lived plasma cells that are present in the bone marrow and are essential to the immune system. Cells are like factories that expel antibodies to protect us from intruders entering our bodies.

“It&#39s almost like bombing a sacred city,” Mina said.

Measles also targets cells in our body, called memory cells. This is a cell that remembers what intruders look like, allowing the immune system to quickly identify and fight them in the future.

When you breathe a virus, it is enveloped in cells called macrophages. Macrophages function as “trojan horses” to collect viruses in lymph nodes, Iwasaki said.

Once there, the virus can bind and destroy these memory cells, wiping away some of our built-in immunity in the process.

“one time [memory cells] As it is excluded, we basically no longer have any memory of those specific pathogens, so we are more susceptible to most infectious diseases that are unrelated to measles,” Iwasaki said.

Will the immune system recover?

The way your body begins to regain immune memory after being surrounded by measles is to be exposed to other viruses and bacteria, get sick again, and boost your immune system.

Such immunity can be relearned, but University of Pennsylvania immunologist John Welley says that while such immunity can be relearned, he is particularly susceptible to other infectious diseases.

“As every parent of a daycare child knows, if you&#39’re building a lot of immunity at the time, you’re suffering through it,” Welley said.

Mina relearned our immunity and compared it to why babies seem to get sick frequently.

“The illness a baby gets is not because the baby is more vulnerable, because they don&#39t have the same immunological memory set yet,” he said. “They have to spend several years accumulating it through exposure, which is kind of what people experience after measles.”

How Measles Causes Brain Inflammation

What&#39s even more frightening is an untreated measles complication called subacute sclerosing pan encephalitis (SSPE), a brain disease that can occur for more than a decade, which is fatal after someone recovers from an infection.

For poorly understood reasons, the measles virus can cause persistent infections and lead to brain damage, leading to cognitive decline, coma, and death.

Researchers believe that SSPE was once considered rare, but is more common than realization. a Review of measles cases in California From 1998 to 2015, SSPE cases were found to occur at a higher rate than expected among children who were not vaccinated.

Dr. Bessie Gibberge, a pediatric infectious disease expert at Northwest Medicine, said the disease is progressive and symptoms occur at normal stages.

“It can start with just a change in personality and a change in behavior,” she said. In children, it can be as subtle as worse performance in school.

The disease then progresses and can eventually lead to seizures and abnormal movements, Siebarghese said. Finally, parts of the brain that regulate vital signs such as breathing, heart rate, and blood pressure can be damaged and can lead to death.

There is no cure for this disease and is almost always fatal. Patients usually survive 1-3 years after diagnosis. In the US, there are usually four to five cases each year, which can be underestimated, says Ratner of Nyu Langone Health.

“It’s probably more common than we think because it’s not always diagnosed,” he said. “But as these outbreaks become more common, I think we will clearly see more cases of SSPE.”

Source: www.nbcnews.com

The Loss of US Government Technical Experts as Doge is Eliminated

Under tech billionaire Elon Musk, the Doge Task Force cuts jobs across the US government

AFP via Getty Images

The independent task force, US Government Efficiency (DOGE), has closed 18F, a group of in-house technical experts focused on improving the efficiency of the US government. The 18th floor consulted with other government agencies about adopting cost-effective technology and built digital services for tasks such as applying for a passport or submitting online taxes.

Initiatives such as the 18F, another government unit of high-tech consultants, and the US Digital Services (USDS), are “a wealth of professional networks, fixers and dreamers who can modernize government services.” Daniel Castro at Information Technology and Innovation Foundation, a Washington, DC-based think tank.

He says the recent rapid elimination of the 18th floor could halt US government projects. He then expressed his skepticism that Doge is the right organisation to replace USDS or 18F to help the US government use the technology efficiently. “I didn't hire a demolition crew to build a skyscraper,” says Castro.

The US government typically spends over $100 billion on IT services each year, but these expensive technology investments don't often work as they are actually promised. According to to the US Government Accountability Office. 18F said it helped to avoid such waste by consulting with federal and state agencies adopting high-tech solutions and determining which companies could deliver on time and on budget Danhongovernment digital services and technology experts.

Three former 18th floor employees who requested anonymity had recently cut jobs New Scientist. It helped digitize the healthcare application system to make states easy access to federal Medicaid funds. These provide health insurance to 70 million Americans, including 40% of all children and 60% of all nurse residents.

Another former employee interactively collaborated with the US Department of the Interior Website This tracks environmental damage caused by the release of petroleum or other harmful substances. Such data helped ensure that the person responsible for the damages, not the taxpayer, would pay to clean it, they said.

Members of the 18th floor also had the National Weather Service updated. Prediction website To make it more user-friendly. The 18F team worked with USDS to develop a free direct file program. This allows participating states to submit their taxes directly to the Internal Revenue Service, instead of purchasing tax preparation software or hiring an accountant. The government estimates that more than 30 million taxpayers from 25 states will be eligible for services in 2025.

The future of these projects is currently uncertain. Since President Donald Trump began his second term in January 2025, he has changed his name, I'll remake it The USDS is a clumsy USDS, led by government civil servant Amy Gleason, but is actually led by high-tech billionaire Elon Musk. Many previous US digital services members have since been fired or resigned.

Musk I was aiming It was on the 18th floor early in Trump's second administration, but former 18th floor employees had not received official “forced” notifications to close the organization until February 28th. Approximately 85 members on the 18th floor were directly affected by the layoffs, and three more received previous acquisition offers.

The combination of 18F exclusion and layoffs and resignation from the previous USDS team means there is no government-wide mission left to develop and build technology. say Former 18th floor employee. A spokesman for the General Services Agency (GSA), a US government organization that provides operational support to all federal agencies, said: “GSA will continue to support the administration's willingness to adopt best-in-class technologies to accelerate digital transformation and modernize IT infrastructure.”

topic:

Source: www.newscientist.com

Orca mother grieving loss of newborn now carrying second calf’s body

overview

  • An orca that carried around a dead calf for several days in 2018 appears to be repeating the same behavior with a newly dead calf.
  • Scientists believe the killer whales are likely expressing sadness.
  • Killer whales are part of an endangered subpopulation known as southern killer whales.

Nearly six years ago, a mother orca attracted international attention when she carried a dead calf for 17 days straight. Sadly, the whale now appears to be repeating what researchers say is an expression of grief over another deceased newborn.

The mother whale, also known as J35 or Tahlequah, was first spotted with her new calf on December 20th. But on Wednesday, researchers with the National Oceanic and Atmospheric Administration photographed a whale with a dead calf on its head off the coast of West Seattle.

“We can confirm that J31 lost the calf and was pushing it around on its head,” Brad Hanson, a researcher at NOAA’s Northwest Fisheries Science Center, said in a press conference Thursday.

He said that when the calf is about to sink, “she seems to do a high arch dive to retrieve the calf, but at that point you can’t really tell if she’s pushing or grabbing the calf.” added. ”

Scientists said they believe Tahlequah likely carried the dead calf as an expression of grief. Whales have a similar wiring structure to humans and other large, long-lived social mammals, Joe Gaydos, scientific director of the Sea Dog Society, an ocean research organization, said at a press conference.

“We have the same neurotransmitters as they do. We have the same hormones as they do. Shouldn’t we have the same emotions that they have? We are a market cornered by emotions.” So I think it’s fair to say she’s sad or grieving,” Gaydos said, adding that similar behavior has been observed in dolphins and non-human primates. added.

Tahlequah, also known as J35, and a dead calf.
NOAA

J35 is part of an endangered subpopulation of whales known as southern killer whales. The death of Tahlequah’s calf and the recent birth of another killer whale left the group at just 73 individuals.

Over the years, Tahlequah has had two surviving calves, both male, one born in 2020.

Southerners have been given tracking numbers by the Center for Whale Research and are closely watched by researchers, photographers and whale watchers, especially if they are near Puget Sound communities like Seattle.

Scientists have been following the story of the dead calf for weeks. Hanson said NOAA researchers discovered the female calf themselves on Dec. 23 after a citizen scientist first noticed the female calf, called J61. They were concerned about the calf’s health at the time because it appeared to be struggling and surfacing unusually, he said.

It is not uncommon for orca pups to die shortly after birth. Michael Weiss, director of research at the Center for Whale Research, said the first year of life is the biggest hurdle to survival.

Approximately 70% to 80% of calves that researchers can record and give identification numbers survive the first few years.

“We don’t know exactly what the survival rate is, probably because so many calves are born and die before they are photographed or recorded,” Weiss says. “Probably 50 percent of calves born will survive the first year.”

NOAA researchers said they are now concerned about Tahlequah’s own health because pushing his calves creates a lot of resistance in the water and requires a lot of energy.

“One thing she probably doesn’t have time for is feeding,” Hanson said. “We are concerned that she is expending so much energy caring for her lost calf.”

This is a typical calving season for southern whales. Hanson said researchers were encouraged by the birth of another killer whale, called J62. The orca was first spotted by observers on Dec. 30 and confirmed by the Cetacean Research Center on New Year’s Day.

“It appears to be very robust,” Hanson said.

Southern killer whales have been the subject of conservation efforts for decades. They are protected under the Marine Mammal Protection Act and were listed as endangered in 2005.

Whales typically spend several months each year along the Puget Sound coastline in Washington state. They live in three pods called J, K, and L, and have evolved to eat primarily fish, including the prized Chinook salmon.

In the early 1960s, many of Minami’s killer whales were killed or captured, and some of the surviving killer whales were put on display in marine parks. As of 1974, surveys showed that only 71 individuals remained in the wild. The population has since fluctuated, reaching a high of 95 people in 1995, but has declined since then.

The main reasons why whales are struggling are a decline in the quality and quantity of their prey and pollution from industrial chemicals such as polychlorinated biphenyls (PCBs) that contaminate their prey and accumulate in their bodies. Additionally, ship noise can disturb whales and prevent communication.

Research shows that unless more aggressive action is taken, the southern population is on a path to extinction. Already, Washington state and federal agencies have invested more than $1 billion in programs to reduce threats to whales. But the essential point still remains. Southerners simply don’t have enough food.

Major rivers that were once rich in salmon, including the lower Snake River, have been dammed, limiting access to and survival of salmon.

“We’re not doing enough on chinook recovery and salmon recovery,” Gaydos said.

For struggling southerners, the loss of a female calf is a devastating blow not only to the mother but to the trajectory of the subspecies as a whole.

“The real limit is the number of females that reach reproductive age and their ability to actually raise calves successfully. So we would like to see more females in the population.” Weiss said.

Source: www.nbcnews.com

Scientists may have uncovered the key to solving a significant weight loss mystery

When it comes to weight loss, one universal truth stands out: losing body fat is challenging, and keeping it off can be even more difficult. A recent study may shed some light on why this is the case: adipose tissue, or body fat, retains a sort of “memory” even after cells have become obese.

“This discovery potentially helps explain the changes that occur in adipose tissue during weight fluctuations,” explained Dr. Ferdinand von Mayen, an assistant professor at ETH Zurich’s Faculty of Health Sciences and Technology, in an interview with BBC Science Focus.

Dr. von Mayen and his team observed transcriptional changes in human cells, which are responsible for regulating genetic material, in individuals’ adipose tissue before and after a 25 percent reduction in BMI. “We found that even after weight loss, the genetic regulation in adipose tissue did not fully return to normal, indicating that the body is programmed to regain lost weight,” he added.

While this news may be disheartening for those on a weight loss journey, Dr. von Mayen hopes that this study will help destigmatize weight fluctuations. “There is a molecular mechanism at play that influences weight regain, and it’s not simply a matter of willpower,” he emphasized.

He also stressed the importance of prevention in addressing the global obesity epidemic. “Early intervention is key, as it is much harder to lose weight once it has been gained. Implementing healthier lifestyle choices at a societal level is crucial in combating this issue,” Dr. von Mayen noted.

About our experts

Dr. von Mayen: I specialize in researching obesity and metabolic diseases at the Nutritional and Metabolic Epigenetics Laboratory at ETH Zurich.

Read more:

Source: www.sciencefocus.com

Study finds new weight loss drug decreases appetite without compromising muscle mass

Researchers have identified a new drug similar to Ozempic that aids in weight loss without causing muscle loss. This drug, known as NK2R, works by suppressing appetite and boosting calorie burning. According to scientists, it has been successful in promoting weight loss while avoiding negative side effects such as nausea. The team of 47 researchers believe that NK2R could be a valuable option for individuals who have not seen results with other weight loss treatments.

Associate Professor Zach Gerhart-Hines, a metabolic researcher at the University of Copenhagen and co-author of the study, noted that their drug, unlike Ozempic, did not trigger nausea and also resulted in muscle relief rather than muscle loss. The drug targets specific neural circuits in the brain and affects blood sugar, weight, and cholesterol levels.

While Ozempic mimics the hormone GLP-1 to reduce hunger, NK2R works differently by targeting a molecule naturally present in the body’s cells called NK2R. When tested on overweight mice, the drug led to weight loss and decreased food intake.

However, some health experts are cautious about the effects of this treatment on humans, as it is currently based on animal studies. Dr. Adam Collins, an associate professor of nutrition at the University of Surrey, expressed skepticism about the research’s applicability to humans.

Clinical trials of NK2R in humans are scheduled to begin within the next two years.

About our experts:

Dr. Zach Gerhart-Hines is an associate professor at the University of Copenhagen, Denmark, focusing on diet, circadian clocks, and metabolism.

Dr. Adam Collins is an Associate Professor at the University of Surrey with expertise in weight loss, metabolism, and nutrition.

read more:

Source: www.sciencefocus.com

The unexpected weight loss caused by Canada’s gravity anomaly

In certain areas of the world, such as Canada’s Hudson Bay, gravity is slightly lower than in other areas.

This is because an object with more mass has more gravity, and since Earth’s mass is not uniform, gravity varies from place to place. However, you need a very accurate scale to notice it. Hudson Bay’s gravity is about four thousandths of a percent lower than Earth’s average.

When scientists discovered this anomaly in the 1960s, they developed two theories to explain it. The first is that the Earth’s crust is still recovering from the last Ice Age.

About 20,000 years ago, the huge Laurentide ice sheet covered North America. The weight of the ice, which was more than 3 kilometers (almost 2 miles) thick in places, pushed down on the continent’s crust.

When the Ice Age ended, the Laurentide melted rapidly, but the Earth’s crust slowly returned to normal. It rebounds by about 12 mm (0.5 inch) each year, meaning it will take another 300,000 years to return to its original position. This indentation left in the Earth’s crust means that Hudson Bay has slightly less mass and therefore slightly less gravity.

The second theory concerns the movement of the mantle beneath the Earth’s crust.

The mantle is made of molten rock heated by the Earth’s core. It rises over geological time scales and then sinks again as it cools. This creates convection currents that move the plates. Ocean currents can also pull continents downward, slightly reducing mass and gravity in the area.

Satellite measurements in 2002 revealed both theories to be correct. The Hudson Bay gravity anomaly is caused by a combination of mantle convection and the legacy of the Laurentide ice sheet. Therefore, even after the Earth’s crust has fully rebounded, gravity in this part of the world will remain slightly lower than average.

This article answers the question (asked by Victor Gregory via email): “Is it true that people in Canada weigh less?”
If you have any questions, please email us at: questions@sciencefocus.com or send us a message facebook, ×or Instagram Page (remember to include your name and location).

Check out our ultimate fun facts More amazing science pages.

read more:

Source: www.sciencefocus.com

Suppressing Appetite to Lose Weight: The Effects of Weight Loss Drugs on Eating and Exercising Desires

Weight loss drugs may reduce people's desire to exercise

Me 3645 Studio/Getty Images

Semaglutide, found in medicines such as Ozempic and Wigovy, reduces the amount of movement in mice. This finding suggests that these weight loss drugs may reduce people's motivation to exercise.

Semaglutide helps treat type 2 diabetes and obesity by mimicking a hormone called GLP-1, which regulates blood sugar and suppresses appetite. GLP-1 also suppresses activity in brain areas involved in reward processing and craving. This may explain why people taking semaglutide-based drugs no longer find eating as rewarding or pleasurable as they did before taking the drug. This is also probably why some studies show that semaglutide may also be helpful in treating substance use disorders.

ralph dileone Researchers at Yale University wanted to know whether semaglutide also affects other rewarding behaviors, such as exercise, which is known to improve mood and memory. So they gave seven mice semaglutide and an equal number a placebo and measured how far the mice ran on an exercise wheel each day.

On average, patients treated with semaglutide ran about half the distance as those given a placebo. This suggests that motivation for exercise may be low.

To further test this, the researchers administered semaglutide to another group of 15 mice and a placebo for 5 days to another group of similarly sized mice, and investigated their willingness to exercise on a wheel. did. But this time, the exercise wheel locked up periodically while the animal was running on it. To release the lock, the mouse had to press a lever with its nose. Each time the wheel locked, it became progressively more difficult to unlock, requiring the mouse to press the lever many more times. “Eventually they quit,” says DiLeone, who presented these findings at the Society for Neuroscience meeting in Chicago on October 7. “We call that their breakpoint. It's a proxy for how willing they are to access the wheel.”

The maximum number of lever presses in the semaglutide-treated mice was, on average, 25% lower than in the control animals. The researchers repeated the experiment in obese mice and found similar results.

Taken together, these findings suggest that semaglutide-based drugs, such as Ozempic and Wigovy, may reduce motivation to exercise, similar to reducing food and drug cravings. Masu. But DiLeone says there's still no evidence that this applies to humans. This could be because most of the data on Wegovy and Ozempic comes from people participating in weight-loss programs that include exercise, he says.

Still, these findings highlight that these drugs can interfere not only with negative behaviors but also with positive ones. ”[This] Data suggests there are still motivated behaviors that can be changed [with semaglutide] I haven't heard it yet.'' Karolina Skibicka at Penn State University.

topic:

Source: www.newscientist.com

The Keto diet promotes weight loss while also raising cholesterol levels

On the keto diet, most of your calories come from fat.

Shutterstock/George Dolgic

The keto diet, which gets most of its calories from fat and few from carbohydrates, can certainly lead to fat loss, but it can also clog arteries and harm your gut flora.

Also known as the ketogenic diet, this diet forces your body to use a different type of fuel. Instead of relying on glucose from carbohydrates, you rely on ketones, a type of fuel your liver produces from your fat stores, which can lead to weight loss.

In previous studies, Comparing people who follow a ketogenic diet to those who don't suggests there are both advantages and disadvantages.

now, Javier Gonzalez Researchers at the University of Bath in the UK conducted the largest randomized controlled trial in medical evidence. They recruited 53 non-obese people with an average age of 34. They randomly assigned about one-third of them to a ketogenic diet, in which less than 8% of energy came from total carbohydrates and more than 70% came from fat.

The remaining third of participants were instructed to follow a low-carbohydrate diet, with 5 percent of their energy intake coming from 'free' sugars – a type of carbohydrate found in foods such as syrup, cakes and biscuits – and 45 percent and 35 percent from other carbohydrates and fat respectively.

The remaining third consumed diets with moderate amounts of free sugars, accounting for just under 20% of their energy intake, while carbohydrate and fat intakes without free sugars were around 30% and 35%, respectively. These participants acted as the control group. Protein intake was between 15-18% across all diets.

After one month, x-rays showed that participants on the ketogenic diet had lost an average of 1.6 kg of fat. The researchers verified that participants were following the diet by measuring ketone levels in their blood, urine, and breath. Food diaries also assessed adherence to the diet.

Meanwhile, those on low-carb diets lost an average of one kilogram of fat, while those on moderate diets lost nothing. By having participants intermittently wear activity monitors to estimate their energy intake, the team found that the fat loss was due to reduced calorie intake, not increased activity, something that hadn't been known before, Gonzalez says.

But despite greater fat loss, the ketogenic diet group had 16 percent higher levels of “bad” low-density lipoprotein (LDL) cholesterol than the control group, and 26 percent higher levels of apolipoprotein B, a protein that clogs arteries and increases the risk of heart-related events. In contrast, people on the low-carb diet had 10 percent lower LDL cholesterol levels than the control group, and no change in apolipoprotein B levels.

The researchers also found that people on a ketogenic diet had lower levels of a type of gut bacteria than those on a moderately low-carb diet. Bifidobacteriawhich Helps produce vitamin B and It has been shown to strengthen the immune systemThe same wasn't true for those on a low-carb diet, likely because those on the ketogenic diet consumed less fiber. Bifidobacteria Level, Gonzalez says.

However, it is unclear whether the ketogenic diet truly has a negative effect on the gut microbiome, because we do not fully know what the optimal diet is or what the full effects of the ketogenic diet are. Bifidobacteria says Natasha Scholer At Great Ormond Street Hospital in London.

Additionally, while elevated apolipoprotein B levels are a concern, the elevated cholesterol levels seen in the study aren't necessarily harmful unless they reach a dangerous threshold, Scholer said.

Longer-term studies are also needed to determine whether the weight-loss benefits of ketogenic diets outweigh potential concerns about cholesterol and gut health in obese people, Scholer said.

Ultimately, the main challenge for obese or overweight people to lose weight is following a diet, says Scholer: “Whether it's a normal carbohydrate diet, a low-calorie diet, or a calorie-for-calorie reduced-carb diet, if you stick to it, you will generally lose weight.”

topic:

Source: www.newscientist.com

A cost-effective, all-natural remedy for hair loss may have been uncovered by scientists

Scientists have made a groundbreaking discovery in the hair loss industry by finding that a naturally occurring sugar in the human body, 2-deoxy-D-ribose (2dDR), could be the key to combating male pattern baldness.

The study, published in the journal The forefront of pharmacology, revealed that this natural sugar treatment is as effective as current FDA-approved treatments with fewer side effects.

Research co-author, Professor Sheila McNeill, highlighted the potential of 2dDR in increasing blood supply to hair follicles and promoting hair growth. The study was initially focused on wound healing, where accelerated hair growth was observed around sites treated with 2dDR.

Testing in mice showed that 2dDR Gel was 80-90% as effective as minoxidil, a common FDA-approved hair loss treatment found in products like Rogaine and Celoxidil. The discovery offers a promising, safer alternative with fewer side effects, as 2dDR is naturally occurring in the body.

Experts, such as Professor Muhammad Yar, stressed the potential benefits of 2dDR in stimulating blood vessel growth, crucial for healthy hair follicles, and promoting hair growth.

While the research is still in early stages, it could provide hope for those suffering from hair loss conditions like chemotherapy-induced alopecia. More studies are needed before 2dDR-based treatments become available, but the results so far are promising.

For men dealing with hair loss, this discovery offers a ray of hope for an effective, natural, and non-invasive treatment option. Further research is warranted to explore its effects on human hair growth and follicle health.

Learn more from our experts:

Sheila McNeill: Professor Emeritus of Tissue Engineering with a focus on translating research into clinical practice.

Muhammad Yar: Associate Professor with expertise in tissue engineered skin and targeted drug delivery.

Claire Higgins: Lecturer specializing in tissue engineering and regenerative medicine, focusing on skin and hair follicles.


Read more:

Source: www.sciencefocus.com

Microsoft IT outage causes $5.4 billion loss for US Fortune 500 companies following CrowdStrike global outage

According to insurers, a global technology outage caused by a faulty CrowdStrike update is estimated to cost Fortune 500 companies in the United States $5.4 billion. Cybersecurity companies have pledged to take measures to prevent such incidents in the future.

The projected economic losses do not factor in tech giant Microsoft, which experienced widespread system outages during the event.


Banking, healthcare, and major airlines are anticipated to bear the brunt of the impact, as reported by insurance company Parametric. Total insured losses for Fortune 500 companies, excluding Microsoft, are estimated to range between $540 million and $1.08 billion.

The CrowdStrike outage led to the disruption of thousands of flights, hospitals, and payment systems, marking it as the largest IT outage in history. Companies across industries are still struggling to recover from the damages. This incident exposed the fragility of modern technology systems, where a single faulty update can halt operations globally.

CrowdStrike, a Texas-based cybersecurity company worth billions, has seen a 22% drop in its shares since the outage. It has apologized for causing the tech crisis and has released a report detailing the issues with the update.

The root cause of the outage was an update pushed to CrowdStrike’s Falcon platform, a cloud-based service aimed at protecting businesses from cyber threats. The update contained a bug that resulted in 8.5 million Windows machines crashing simultaneously.

CrowdStrike has committed to conducting more thorough testing of its software before updates and implementing staged updates to prevent similar widespread outages in the future. It also plans to provide a more detailed report on the outage’s causes in the upcoming weeks.

As one of the largest cybersecurity companies globally, valued at around $83 billion prior to the outage, CrowdStrike serves many Fortune 1000 companies worldwide. The impact of the failed update was substantial due to its broad reach, underscoring how heavily reliant companies are on similar products for their operations.

Skip Newsletter Promotions

Several companies continue to face challenges in recovering from the outage, with Delta Air Lines still experiencing disruptions after canceling or rescheduling numerous flights. This situation has left frustrated passengers stranded. Panicked Parents Delta Air Lines has launched an investigation into reaching the affected children, and the U.S. Department of Transportation is investigating its handling of the matter.

Source: www.theguardian.com

Scientists claim that fat can be burned naturally in new weight loss discovery

Weight loss can be a challenging journey, but there may be a breakthrough discovery that could make it easier. Scientists have found a way to burn calories without changing your diet or exercising, thanks to a fat-burning mechanism in your body known as “beige fat.”

While diet and exercise are still crucial, researchers from the University of San Francisco have identified a way to convert regular white fat cells into beige fat cells.

In most mammals, including humans, there are three types of fat cells: white, brown, and beige. White fat cells store calories, brown fat cells burn energy for heat, and beige fat cells can do both.

This conversion from white to beige fat cells allows the body to naturally burn fat more efficiently.

Although the study was conducted with mice, it could pave the way for new weight-loss drugs and shed light on why previous trials have not been successful.

Scientists believed that stem cells were required to create beige fat, but the research shows that by inhibiting the production of a protein called KLF-15, white fat cells can be converted to beige fat cells. This finding offers promising insights into potential weight-loss treatments.

Feldman and his team discovered that KLF-15 controls the levels of the Adrb1 receptor, which plays a role in maintaining energy balance. Targeting this receptor with drugs could be a more effective approach for weight loss compared to current treatments.

By understanding the mechanisms behind beige fat cells, researchers hope to develop safer and more long-lasting weight-loss solutions for the future.

read more:

Source: www.sciencefocus.com

The Effects of Lymphatic “Weight Loss Massage” on Your Body

In the beauty industry, treatments to combat bloating and cellulite are in high demand. Celebrities like Jennifer Aniston, Kim Kardashian, and Sean “Diddy” Combs are now turning to lymphatic drainage massage for help with these issues.

This type of massage targets the lymphatic system, which sets it apart from other massage therapies like Swedish, sports, deep tissue, and aromatherapy. Each type of massage offers different benefits, so choosing the right one depends on the results you want to achieve.

Understanding the Lymphatic System

The lymphatic system is a crucial part of the body’s immune system, consisting of organs like the spleen, tonsils, bone marrow, and thymus. It works alongside the circulatory system by filtering out waste products and abnormal cells through lymph nodes. The lymph fluid helps maintain fluid balance, absorb fat, and defend against infections.

Who Benefits from Lymphatic Drainage Massage?

People with conditions like lymphedema, fibromyalgia, sports injuries, deep vein thrombosis, and cancer-related lymphatic buildup can benefit from lymphatic drainage massage. Athletes also find it useful for recovery and prevention, along with proper hydration, diet, exercise, and sleep.

Do You Need Lymphatic Drainage Massage?

Signs of a malfunctioning lymphatic system include swelling in knees, ankles, and hands, as well as swollen lymph nodes when sick. After cancer treatment, lymphatic drainage massage can help prevent infections and support healing.

Can Lymphatic Drainage Help with Weight Loss?

Lymphatic drainage massage can aid in weight loss by improving circulation, reducing swelling, and eliminating toxins. While it may improve the appearance of cellulite, it cannot completely remove it. Weight loss post-massage is often due to losing excess fluids.

What to Expect from Lymphatic Drainage Massage

There are two types of lymphatic drainage massage: manual and simple, both overseen by qualified practitioners. The techniques involve gentle pressure to clear and absorb toxins, without causing pain or skin irritation.

Source: www.sciencefocus.com

New GLP-1 medications offer potential for weight loss and improved health

Exciting developments are on the horizon in the world of obesity medications.

Pharmaceutical companies are racing to create new drugs, building on the success of existing medications like Novo Nordisk’s Ozempic and Wegovi, as well as Eli Lilly’s Maunjaro and Zepbound.

In addition to targeting diabetes and weight loss, some experimental drugs show promise in improving liver and heart function while reducing common side effects such as muscle loss seen with current treatments. Data on 27 GLP-1 drugs in development will be presented at the 2024 American Diabetes Association meeting in Orlando, Florida.

According to Marlon Pragnell, PhD, the ADA’s vice president of research and science, the pipeline now includes a variety of drug candidates in different stages of development, creating an exciting landscape of innovation.

While most of the data currently available comes from animal studies or early human trials, some drugs may be available in the United States over the counter within a few years, with FDA approval likely further down the line.

As the field of GLP-1 drugs continues to expand, there is hope for more affordable medications with fewer side effects to become available, offering new possibilities for patients.

Exploring Different Hormones for Weight Loss

GLP-1 drugs function by slowing down the digestive process and promoting a sense of fullness. In addition to GLP-1, emerging weight-loss drugs are examining the impact of another hormone called glucagon, which can mimic the effects of exercise.

One such drug, Pemvidutide from Maryland-based Altimmune, combines glucagon with GLP-1 to potentially enhance weight loss effects.

Results from a Phase 2 trial involving obese or overweight adults showed promising weight loss outcomes, paving the way for further research into the drug’s potential benefits.

Altimmune’s Chief Medical Officer, Dr. Scott Harris, highlighted the drug’s ability not only to aid in weight loss but also to provide additional health benefits for liver and heart function while preserving lean body mass.

Altimmune plans to move forward with Phase 3 trials and aims to introduce the drug in the U.S. by 2028.

Competition and Cost Considerations

Having a variety of weight-loss drugs available can help address shortages and potentially drive down costs over time. The high prices of current medications like Wegobee and Zepbound in the U.S. can pose financial challenges for many patients.

Different patients may respond differently to various treatments, as highlighted by Dr. Fatima Cody Stanford of Harvard Medical School. Having a range of options is crucial to tailor treatments to individual needs.

Stay Informed with the Latest News on Weight Loss Drugs

New developments in the pharmaceutical world present opportunities for improved treatment outcomes and potentially life-changing solutions for patients struggling with obesity.

For individuals like Danielle Griffin, who have not seen the desired results from current medications, the prospect of innovative drugs offers hope and excitement for the future.

Advancements in Metabolic Health

Companies like Eli Lilly are exploring new combinations of hormones to enhance the efficacy of weight-loss drugs. Retatortide, a new injectable medication from Lilly, shows promising results in weight loss and blood sugar control.

Additional studies on drugs like Mazduchid highlight the potential for improved metabolic status and weight loss outcomes, paving the way for new treatment options in the near future.

These ongoing developments underscore the dynamic landscape of obesity treatment, offering hope for a new generation of medications that could revolutionize the field and improve outcomes for patients.

The Future of Obesity Treatment

As research and development in the field of obesity medications continue to advance, there is optimism for more effective, affordable, and patient-friendly treatments to become available in the coming years.

With the potential for improved metabolic health, weight loss outcomes, and reduced side effects, the next wave of obesity treatments holds great promise for individuals struggling with obesity-related health issues.

The ongoing innovation in this field signifies a new era of possibilities in obesity treatment, offering hope for a healthier future for many individuals.

Source: www.nbcnews.com

The unexpected impact of weight loss drugs on your mental wellbeing and cognitive function

ADDICTIVE STOCK CREATIVES/Alamy; AdoBe Stock

Kathy Schwartz had been sober for 10 years, but battling cravings was a daily struggle. “They were always in my head,” she said. But last June, the cravings subsided.

After being prescribed the weight-loss drug semaglutide, she not only lost nearly 30 kilos over 10 months, but also eliminated her desire for drinks or pills. “The cravings went away, and I didn’t realize that was a side effect,” Schwartz says. Amazingly, the depression and anxiety that had previously hit her in waves also subsided.

Schwartz isn’t the only one to have had this experience: New research is showing that semaglutide drugs like Ozempic and Wegovy, as well as other diabetes and weight-loss drugs that mimic gut hormones released after eating, can have surprising benefits for brain and mental health.

Though it’s still early days, evidence suggests that these drugs could potentially be repurposed to treat depression, anxiety, addiction, and even certain eating disorders, as well as neurological diseases like Parkinson’s and Alzheimer’s. What’s more, these benefits appear to be mediated not simply through weight loss, but through a direct effect on the brain.

The history of drugs like Ozempic dates back to the 1970s and 1980s, when researchers discovered them. A gut hormone called glucagon-like peptide 1 has been discovered. When GLP-1 was injected into rodents in the lab, it was able to stimulate insulin secretion. Even more amazingly, these animals started to eat less and lose weight. We now know that this hormone leads to an increased feeling of fullness.

Semaglutide, etc.

Today, there are drugs that mimic…

Source: www.newscientist.com

The Impact of Lymphatic “Weight Loss Massage” on Your Body

There is a growing trend in the beauty industry to seek treatments for bloating and cellulite, with lymphatic drainage massage becoming increasingly popular among A-list celebrities like Jennifer Aniston, Kim Kardashian, and Sean “Diddy” Combs.

These celebrities have touted the fast health benefits and weight loss advantages of this treatment, but what exactly does lymphatic drainage massage do?


Lymphatic drainage massage is unique as it targets the lymphatic system, setting it apart from other massage therapies such as Swedish, sports, deep tissue, and aromatherapy. Each type of massage offers different benefits, so your choice depends on your desired results.

The lymphatic system is a crucial part of the body’s immune system, consisting of tissues, organs like the spleen and bone marrow, and a network of interconnected blood vessels and lymph nodes. These components work together to filter out waste and maintain fluid balance, producing white blood cells to fight infections.

People opt for lymphatic drainage massage to combat cellulite as the treatment aids the absorption of fat and excess fluids back into the bloodstream.

Lymphatic drainage massage can benefit those dealing with lymphedema, fibromyalgia, sports injuries, deep vein thrombosis, and lymphatic buildup post-cancer treatment. While athletes benefit from preventative and restorative sports massages, lymphatic drainage massage can aid recovery after injury or surgery.

If your lymphatic system is not functioning optimally, you may experience swelling and puffiness in various parts of the body. Lymphatic drainage massage can help alleviate these symptoms by improving circulation, reducing swelling, and eliminating toxins.

While lymphatic drainage massage may improve the appearance of cellulite, it cannot completely remove it. The treatment may lead to temporary weight loss due to the elimination of excess fluids.

During a lymphatic drainage massage, the therapist employs gentle pressure techniques that do not cause discomfort or skin redness. The massage focuses on clearing and absorbing, enhancing skin health.

Source: www.sciencefocus.com

A fresh perspective on tinnitus and hearing loss may offer potential for their reversal

Ten years ago, while working as a DJ in Liverpool, England, James Rand would often leave work hearing strange sounds he knew weren't real: high-pitched growls or low-pitched rumblings. . These tinnitus symptoms always went away by the time he woke up… and one day in 2017, they didn't go away.

Doctors confirmed that the sounds were probably caused by Rand's exposure to loud music for hours at a time. There was no cure, no way to get him used to it. “I thought I would never hear silence again,” he says. “He was incredibly depressed.”

But today, the outlook for tinnitus treatment is not so bleak. New research has developed a neurostimulator that reduces the volume of sounds. Additionally, there are several treatments in development that can even stop tinnitus completely. “For the first time, we are discussing potential treatments,” he says. Stéphane Maison at Harvard Medical School.

These insights also shed light on common causes of hearing loss. In fact, they suggest that the same treatments for tinnitus may also restore hearing in people who have become partially deaf due to aging. “The way we think about hearing loss has completely changed,” Maison says.

What is tinnitus?

Tinnitus is one of the most common long-term medical conditions. Affects up to a quarter of older adults. While the crying and rumbling sounds that Rand experiences are common, others may hear whistling, humming, clicking sounds, and even musical hallucinations. Sound can be annoying and distracting, and in some cases can cause depression and anxiety…

Source: www.newscientist.com

New Weight Loss Drugs Could Drastically Reduce Obesity in the Next Few Decades

Obesity has undergone a significant shift in how we perceive it in recent years. It was once seen as a personal lifestyle choice, but is now acknowledged as a complex disease affected by genetics, biology, psychosocial factors, and the environment. It is a prevalent condition affecting a large portion of the population.

The World Health Organization (WHO) estimates that around 2 billion adults are overweight or obese and this number is rising rapidly across different income countries.

Obesity poses a major health risk as it increases the likelihood of developing diseases such as diabetes, heart disease, dementia, cancer, nonalcoholic fatty liver disease, and kidney failure.

Recent advancements in understanding obesity have revealed that the regulation of energy balance and eating behavior occurs in the brain, not the stomach. Scientists have identified numerous genes that impact weight regulation and predispose individuals to obesity. Additionally, maintaining weight loss is challenging due to the body’s natural responses, which slow metabolism and increase hunger hormones.

Efforts to find effective treatments for obesity have intensified, considering the stigma and discrimination individuals with obesity often face. Traditional methods such as surgery or lifestyle changes like diet and exercise have been common strategies for weight loss. However, these approaches come with risks, limitations, and costs.

Current weight loss drugs have not been very successful in achieving significant results. New gut hormone treatments known as incretins show promise in managing obesity by regulating appetite through the gut-brain axis. Drugs like semaglutide have demonstrated notable weight loss benefits and improved blood sugar levels, offering hope for effective obesity management in the future.

Despite the potential of new weight loss drugs, challenges like administration methods, cost, and long-term effectiveness need to be addressed. Developments in weight loss medications, including oral drugs like orforglyprone, are still in progress, suggesting a promising future for obesity treatment.

While weight loss pills offer a valuable tool, they should be part of a comprehensive approach that includes lifestyle changes, psychological support, and addressing socio-economic factors influencing health inequalities. The future of obesity treatment looks promising with ongoing research and advancements in medical technology.

It’s crucial to recognize that a holistic approach, which combines different strategies tailored to individual needs, is essential in effectively addressing the complexities of obesity. By destigmatizing obesity and focusing on a well-rounded treatment plan, we can make significant strides in managing this chronic disease.

Read more:

Credit: Getty Images

Source: www.sciencefocus.com

New experimental weight loss drug shows greater effectiveness than Ozempic

Oral weight loss drug may help obese patients who hate needles

Kseniya Ovchinnikova/Getty Images

Based on early trial results reported on March 7, it appears the experimental pill may cause greater weight loss than existing injectable treatments such as Ozempic, Wigoby, and Munjaro.

The drug, called amicretin, reduced people’s weight by 13 percent in three months. This is more than double his amount observed at Ozempic and Wegoby specifically. “From the limited data we have, this approach seems a little more exciting,” he says. Daniel Drucker At the University of Toronto, Canada.

The results come from a three-month, placebo-controlled trial, so it’s too early to know how amicretin compares to other drugs in terms of long-term efficacy and safety. said Drucker, who was not involved in the trial but was consulted, as well as manufacturer Novo Nordisk and other drug companies.

The diabetes drug Ozempic and the weight loss drug Wegoby are two brand names for the compound semaglutide. They work by mimicking a gut hormone called GLP-1 that is normally released after meals. This makes a person feel full, reduces appetite, and stimulates the release of the blood sugar-regulating hormone insulin.

Semaglutide leads to a loss of about 15 percent of body weight when taken for a year, but after that the weight plateaus and the injections need to be continued for a long time or it tends to gradually come back.

Another weight loss injectable called Mounjaro, also known as Tirzepatide or Zepbound, was launched last year. It mimics GLP-1 and an additional intestinal hormone called GIP. Using Mounjaro, you seem to lose about 21 percent of your weight over the first year and five months of her life before your weight loss plateaus.

However, amicletin mimics GLP-1 and another hormone called amylin, and appears to be even more potent, at least during the first three months of treatment. Reuters reports that people who took amicletin lost 13 percent of their weight during this period, Nordisk announced today. Those who took the placebo pill had a 1% decrease. This is higher than Wegovy and Ozempic’s 6 percent and Munjaro’s equivalent figure of around 7.5 percent.

But we can only know for sure how the drugs will fare over the long term if they are compared under exactly the same circumstances in a single study, Drucker said. “This is not a head-to-head trial.”

Another caveat is that while drugs that act by mimicking GLP-1 have been used to treat type 2 diabetes for more than a decade and their safety profile is well understood, amylin mimetics That’s not the case.

Novo Nordisk also said: Amicretin’s side effects were similar to those of Wegoby, and tended to include nausea, vomiting, and diarrhea, especially when the dose was increased rapidly.

The availability in pill form could be a big advantage for people who don’t like injections, he says. Daniel Chancellor Global Pharmaceutical Business Analyst cytherine. “Oral medications are very attractive.”

In addition to these three drugs, other weight loss drugs that mimic other gut hormones are also in development.

topic:

  • Medical drugs /
  • weight loss

Source: www.newscientist.com

Keto diet aids in sustaining weight loss post-Ozempic discontinuation

Ketogenic diet may help prevent weight gain

Shutterstock / Brent Hofacker

Type 2 diabetics who have stopped taking weight loss drugs such as Ozempic or Wegovy can avoid regaining lost weight by adopting a ketogenic diet. This finding from a small study challenges the concept that people must take these drugs indefinitely to prevent unwanted weight gain.

Ozempic and Wegovy belong to a class of drugs called GLP-1 agonists, which reduce appetite and stimulate the release of insulin. These are commonly prescribed to help people with type 2 diabetes regulate their blood sugar and lose weight. However, the assumption was that people would have to continue taking the drug over a long period of time or they would regain the weight they had lost.

Shaminy Athinarayanan The woman and her colleagues at Virta Health, a US telemedicine company that treats type 2 diabetes, decided to test that assumption. Their inspiration to do so came from previous research showing that low-carbohydrate diets like the ketogenic diet help people with type 2 diabetes manage blood sugar levels and weight.

Researchers tracked the weight and blood sugar levels of 308 adults with type 2 diabetes living in the United States who received nutritional therapy at Virta Health. They were all using GLP-1 agonists at enrollment. Participants were advised to follow a ketogenic diet. They were instructed to eat less than 30 grams of carbohydrates each day, or less than 50 grams if vegan, and about 1.5 grams of protein per kilogram of body weight each day. They were encouraged to eat until they were full, regardless of calories. Health coaches and qualified medical professionals communicated virtually with participants as needed.

After 3 to 9 months, half of the participants stopped using the GLP-1 agonist. All participants continued on the ketogenic diet for an additional year. At this point, the researchers found no significant differences in body weight or blood sugar levels between the two groups. On average, participants who stopped taking GLP-1 agonists gained only about 1 kg. In contrast, those who continued taking the drug gained about 2 kg. Most participants in both groups had blood sugar levels below the diagnostic criteria for diabetes.

“This study suggests that continued use of GLP-1 agonists is not necessary for many people if: [they] Appropriate intervention is required,” says Athinarayanan. “You can stop. [these medications] Maintain weight and blood sugar levels safely and effectively. ”

It says this could be helpful for people who can’t take the drug due to shortages or side effects. priya jaisinghani At New York University Langone Health. But she says people should talk to their doctor before starting a low-carb diet, as there can be risks, especially for people with underlying health conditions like kidney disease or eating disorders. He also noted that the study was sponsored by Virta Health and had a small number of participants. So “this is not the be all and end all,” Jaisinghani said. “But it shows the difference that diet makes.”

topic:

Source: www.newscientist.com

Supplements containing resistant starch could assist in weight loss

Raw oats are a natural source of resistant starch

Mark Oliver/Alamy

Supplements containing resistant starch, a type of carbohydrate that takes time to digest, helped people moderately lose weight in a small trial.

Resistant starch is naturally found in beans, whole grains, raw oats, and green bananas, and is also formed when common starchy foods like potatoes, pasta, and rice cool after cooking.

Resistant starch comes in several different forms, but what they have in common is that the structure of the molecule means that it is not easily digested and absorbed in the small intestine.

Therefore, the starch reaches further into the intestine, into the large intestine, where it is digested by bacteria. This means that starch is classified as a prebiotic.

Although some previous studies have suggested that this starch can help with weight loss, Lihuatei Researchers from the Shanghai Jiao Tong University School of Medicine in China studied its effects on gut bacteria.

Researchers asked 37 overweight people to consume sachets of starch mixed with water twice a day before meals. For eight weeks they were given resistant starch, and for a further eight weeks they were given packets containing regular starch as a comparison. Participants were also provided with three balanced meals a day and various health indicators were measured.

After consuming resistant starch for eight weeks, people lost an average of 2.8 kilograms, while regular starch had no effect on weight. Resistant starch causes less rise in blood sugar levels after meals and is considered to be good for health.

Stool samples revealed that while people consumed resistant starch, the numbers of several bacterial species increased in their intestines. When these bacteria were transplanted into mice fed a high-fat diet, they appeared to have a weight-loss effect.

Rebecca McManamon A spokesperson for the British Dietetic Association said the trial was too small to be conclusive, but the results were plausible. “These outcomes are natural,” she says.

However, some people with irritable bowel syndrome may feel bloated and uncomfortable when they eat resistant starch, as the bacteria produce gas as they break down, she says.

topic:

  • carbohydrates/
  • weight loss

Source: www.newscientist.com

New research on Zinc sheds light on the link between loud noise and hearing loss

Exposure to loud noises, such as at music festivals, can worsen your hearing

Sergei Ilnitsky/EPA-EFE/Shutterstock

Exposure to loud noises can disrupt zinc levels in the inner ear, potentially affecting hearing, a study in mice suggests. Treatments that reduce this could be used to treat or prevent such damage, for example, if taken before a rock concert.

Loud noises can cause cells in the inner ear die. Although it has long been known that this affects hearing, the mechanisms behind it are less clear.

Thanos Tsonopoulos Researchers at the University of Pittsburgh, Pennsylvania, thought it might have something to do with free-moving zinc, which plays an important role in the neurotransmission of our senses.

Most of the zinc in the body is bound to proteins, but the rest acts as communication signals between organs, especially the brain, Tsonopoulos says. The highest concentration of free zinc in the body is in the cochlea, the snail-shaped structure in the inner ear that converts vibrations into electrical signals, which are then interpreted as sound.

To learn more, Tzounopoulos and colleagues tested free zinc levels in young mice that had been genetically engineered to produce biological markers that indicate the transport of free zinc throughout the body.

Tsonopoulos said mice exposed to 100 decibels of noise, about the same level as a bulldozer or motorcycle, for two hours straight developed significant hearing loss within the next 24 hours.

The researchers found that these mice had higher amounts of free zinc between and around the cells of the cochlea after the blast compared to before the blast and compared to a group of control mice that did not hear the loud noise. I discovered that

“There is a very strong upregulation of zinc, not only in terms of quantity but also in terms of regional spatial extent,” he says. “It goes everywhere.”

Tsonopoulos said the zinc appears to be released from specific cells in the cochlea after it is separated from the proteins to which it is normally bound. Free zinc ultimately causes cell damage and disrupts normal communication between cells, he says.

To see if lowering free zinc levels could protect hearing, Tsonopoulos and his team injected another group of mice with a compound that scavenged zinc into their abdomens or administered a slow-release drug into the inner ear. It was treated by placing an implant. The mice then listened to the same loud sound for two hours. Both groups experienced significant reductions in hearing loss.

With further research, zinc-capturing tablets, IV drugs, or slow-release implants could one day help prevent or treat inner ear damage caused by noise trauma, Tsonopoulos says.

“You can go to concerts, you can go to battle, you can take drugs,” he says. “Or, if you have an accident, you might have these compounds in your ER. [emergency room] We will give it to you to reduce the damage. ”

Future research should also determine how long after exposure to noise people can benefit from such zinc trap therapy, team members say. Amantha Satyaalso at the University of Pittsburgh.

topic:

Source: www.newscientist.com

The reasons behind diet failures, as explained by a weight loss surgeon, and the key to successful eating.

Perhaps many of us have attempted to reduce our waistline by watching our calorie intake or hitting the gym, only to find little success. Should we be doing things differently?

According to Dr. Andrew Jenkinson, a consultant bariatric surgeon at University College London Hospital and the author of “Why do we eat (overeating)?” and “How to eat (and still lose weight)”, losing weight has more to do with eating foods that manage levels of leptin hormone rather than focusing on calorie counting or exercise.

So what exactly is leptin, and how does it work? Dr. Jenkinson shared insights in a recent discussion with us about leptin, food consumption, and strategies to reduce appetite.

When it comes to the problem of obesity, Dr. Jenkinson views it as a major health and economic issue that could lead to the collapse of healthcare systems. He highlighted the prevalence of obesity-related conditions such as type 2 diabetes, high blood pressure, sleep apnea, joint problems, and an increased risk for cancer.

Leptin, a hormone secreted by fat cells, regulates body weight by signaling the hypothalamus, the weight control center of the brain. However, certain foods can block leptin signals, such as sugar, refined carbohydrates, and processed foods, which increase insulin levels and block leptin.

Dr. Jenkinson emphasized that the concept of calories alone is not an effective approach to weight loss. Instead of focusing on calorie counting, he suggested avoiding foods that negatively impact insulin, which can shift the weight set point downward without significant effort.

In terms of exercise, Dr. Jenkinson explained that intense exercise can burn calories, but it can also lead to increased hunger and decreased metabolic rate if not balanced with calorie restriction. He recommended a combined approach of calorie restriction and intense exercise to achieve effective weight loss.

This interview with Dr. Andrew Jenkinson has been edited for clarity and length.

Dr. Andrew Jenkinson is a Consultant in Bariatric (Weight Loss) and General Surgery at University College London Hospital and the author of “Why do we eat (overeating)?” and “How to eat (and still lose weight).”

Source: www.sciencefocus.com

New Weight Loss Drugs: Will Ozempic, Wegovy and Future Solutions Finally Conquer Obesity?

There are TikTok hashtags with millions of followers, endless columns about celebrity waistlines, and a flurry of media coverage when test results come out. It is rare for a new drug to receive so much attention. However, it is even more rare for approved drugs to cause safe and rapid weight loss with minimal effort.

A year ago, most people had never heard of semaglutide. Semaglutide is a drug developed about 10 years ago under the brand name Ozempic to treat type 2 diabetes. It was later approved as a weight loss aid in the US in 2021 under the name Wegovy. With this drug, people can lose a whopping 15% of their body weight.

The impact of this new class of medicines could be unprecedented and could end the world's growing obesity epidemic. “I don’t think it’s fully sunk in yet,” he says. Jonathan Campbell At Duke University in North Carolina, he studies how these drugs affect the body.

First, Wegovy was just the beginning. The next generation of these drugs is in development and will be cheaper, easier to use, and, importantly, even more powerful. Additionally, new evidence suggests that Wegovy and its similar products are more effective when given at a younger age, so doctors are considering their use in teenagers and young children. This increases the possibility of switching from obesity treatment to prevention. “Over the past 40 years, we have seen the obesity landscape change dramatically,” Campbell says. “Now we may be at a tipping point where that goes backwards.”

Why is obesity on the rise?

The rise in obesity has been occurring since the 1970s…

Source: www.newscientist.com

Probiotics found effective in reducing fatigue and memory loss related to prolonged COVID-19 infection

Probiotics, illustration of live microorganisms that can affect intestinal bacteria

ART-ur/Shutterstock

A daily cocktail of prebiotics and probiotics can help reduce fatigue, memory, and symptoms in people with long-term COVID-19 (symptoms that persist for months or years after being infected with COVID-19). May be useful in treating gastrointestinal complaints.

Although little is understood about long-term coronavirus infections, previous research has shown that people with the disease have lower levels of certain gut microbes than those without. Masu. In particular, they lack gut bacteria that produce compounds called short-chain fatty acids that regulate immune responses.

Siu Ng and his colleagues at the Chinese University of Hong Kong have formulated a mixture that boosts the production of short-chain fatty acids. The product, called SIM01, contained three probiotics (live bacterial strains) and three prebiotics (compounds that help the growth of beneficial gut bacteria).

They distributed this cocktail to 232 adults. Another group of 231 adults took a mixture containing starch and low-dose vitamin C. Both mixtures were taken twice a day for 6 months. All participants were residents of Hong Kong, had previously tested positive for COVID-19, and met the U.S. Centers for Disease Control and Prevention’s criteria for long-term COVID-19 infection.

Researchers used a questionnaire to assess 14 long-term COVID-19 symptoms in participants before treatment began and after treatment ended. At the end of the trial, people who received SIM01 were likely to experience relief from five long-term coronavirus symptoms: fatigue, memory loss, difficulty concentrating, general unwellness, and gastrointestinal upset. It was found to be about 2 to 2.5 times higher on average. The research team also found no serious side effects from the treatment.

Analysis of fecal samples taken before and after the trial revealed that SIM01 increases gut microbial diversity and promotes the growth of beneficial gut bacteria, Ng said. Therefore, she says, it could be useful in treating other conditions that are associated with disruption of the gut microbiome, such as chronic fatigue syndrome.

However, it is unclear how these changes in the gut reduce the symptoms of long-term coronavirus infection. timothy sampson At Emory University in Georgia. “It makes sense that the microbiome has the ability to mediate immune responses, but… [immune system] What is actually at the root of [long covid] You get symptoms,” he says.

topic:

Source: www.newscientist.com

The microbiome may be linked to memory loss in Alzheimer’s disease, new study finds

A groundbreaking study proves that Alzheimer’s disease symptoms can be induced in healthy animals through gut microbiome transmission, highlighting the gut-brain connection and suggesting early treatment and treatment of Alzheimer’s disease. New avenues for personalized interventions have been opened.

Researchers have discovered a link between the gut microbiome and gut bacteria. Alzheimer’s disease disease.

For the first time, research has demonstrated that symptoms of Alzheimer’s disease can be transmitted to healthy young organisms through the gut microbiome, confirming its role in Alzheimer’s disease.

The research was led by Professor Yvonne Nolan from APC Microbiome Ireland, the world’s leading SFI-funded research center based at University College Cork (UCC), and Professor Yvonne Nolan from UCC’s Department of Anatomy and Neuroscience. Professor Sandrine Thure, King’s College London, and Dr. Annamaria Cattaneo, IRCCS Fatebenefratelli, Italy.

Scientists have discovered a link between Alzheimer’s disease and the gut microbiome. Pictured are Dr. Stephanie Grabracer and Professor Yvonne Nolan. Credit: UGC

This study confirms that the gut microbiome is emerging as an important research target for Alzheimer’s disease, given its sensitivity to lifestyle and environmental influences.

was announced on brainThis study shows that memory impairment in Alzheimer’s patients can be transferred to younger animals through gut microbiota transplantation.

Alzheimer’s disease, memory impairment, gut microbiome

Patients with Alzheimer’s disease had greater abundance of pro-inflammatory bacteria in their fecal samples, and these changes were directly correlated with the patients’ cognitive status.

Professor Yvonne Nolan said: “The memory test we investigated relies on the growth of new neurons in the hippocampal region of the brain. Animals with the gut bacteria of Alzheimer’s patients produced fewer new neurons and had impaired memory. I found out that it is true.”

“Alzheimer’s patients are typically diagnosed at or after the onset of cognitive symptoms, which may be too late, at least with current treatments. “Understanding the role of gut bacteria could pave the way for the development of new treatments and even personalized interventions,” Professor Nolan said.

Implications for treatment strategies and research collaborations

Alzheimer’s disease is the most common cause of dementia and is a general term for memory loss and other cognitive impairments severe enough to interfere with daily life. As the population ages, one in three people born today could develop Alzheimer’s disease. Funded by Science Foundation Ireland, scientists at UCC are leading the way in healthy brain aging by investigating how the gut microbiome responds to lifestyle influences such as diet and exercise. We are working to develop strategies to accelerate and advance the treatment of Alzheimer’s disease.

Professor Sandrine Thuret, Professor of Neuroscience at King’s College London and one of the study’s senior authors, said: ‘Alzheimer’s disease is an insidious disease and there is still no effective treatment. , represents an important advance in the understanding of this disease, confirming that the composition of our gut microbiota is causally linked to the development of the disease. This collaboration will help future research in this field. We hope that this will lead to potential advances in therapeutic interventions.”

Professor. John F. Cryan, vice president of research and innovation at UCC, who also worked on the study, said: He conducts research into related diseases such as Alzheimer’s disease, and with UCC he recognizes APC Microbiome Ireland as a leading institution in microbiome and brain health research. This research is consistent with our UCC Futures Framework and the University’s strategic plans in the areas of food, microbiome, health and, soon to be launched, Future Aging and Brain Sciences. “

Reference: “The microbiota of Alzheimer’s patients induces defects in cognition and hippocampal neurogenesis” Stephanie Grubrucker, Moira Marizzoni, Edina Silajzic, Nicola Lopizzo, Elisa Mombelli, Sarah Nicolas, Sebastian Dom-Hansen, Katia Scacellati, Davide Vito Moretti, Melissa Rosa, Carina Hoffman, John F. Cryan, Olivia F. O’Leary, Jane A. English, Aongus Lovell, Cora O’Neill, Sandrine. Ture, Annamaria Cattaneo, Yvonne M. Nolan, October 18, 2023; brain.
DOI: 10.1093/brain/awad303

The research was carried out by Dr Stephanie Grubrucker, a postdoctoral researcher in collaboration with Professor Nolan, in collaboration with postdoctoral colleagues Dr Edina Siladzic from King’s College London and Dr Moira Marizzoni from IRCCS Fatebenefratelli in Italy. It was carried out. UCC collaborators were Professor Cora O’Neill, Dr Olivia O’Leary, Dr Sarah Nicholas, Dr Jane English, Mr Sebastian Dohm Hansen and Dr Aongus Lovell.

Source: scitechdaily.com